Related Experiment Videos
The structure of docking domains in modular polyketide synthases.
R William Broadhurst1, Daniel Nietlispach, Michael P Wheatcroft
1Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, CB2 1GA, Cambridge, United Kingdom.
Chemistry & Biology
|September 5, 2003
Summary
Engineering polyketide synthases offers drug discovery potential. Researchers determined the NMR solution structure of key protein domains, revealing their role in enzyme assembly and dimerization.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Polyketides from actinomycete bacteria are crucial for many medicines.
- Modular polyketide synthases (PKS) are promising targets for engineering variant molecules.
- Understanding PKS assembly is key to harnessing their drug discovery potential.
Purpose of the Study:
- To elucidate the structural basis of protein-protein interactions in modular polyketide synthases.
- To identify the key interactions mediating docking and dimerization between enzyme modules.
Main Methods:
- Nuclear Magnetic Resonance (NMR) spectroscopy was used to determine the solution structure.
- A 120-residue polypeptide representing a typical pair of terminal docking domains was engineered and studied.
Main Results:
- The engineered polypeptide adopted a stable dimeric structure in solution.
- The structure revealed the detailed role of predominantly helical domains in docking and dimerization.
- This provides insight into the assembly of the PKS enzyme complex.
Conclusions:
- The determined structure clarifies the mechanism of PKS assembly line organization.
- This work facilitates rational engineering of PKS for novel drug discovery.
- The findings are critical for understanding the biosynthesis of complex polyketides.